Latest debt-to-equity ratio
Telix Pharmaceuticals Debt-to-equity ratio
Direct answer
Telix Pharmaceuticals's debt-to-equity ratio is 118.9%.
The verified market snapshot reports 118.9%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 10, 2026.
Get free Telix Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 118.9%
Explore related company data
View Telix Pharmaceuticals's market capitalizationView Telix Pharmaceuticals's p/e ratioView Telix Pharmaceuticals's price-to-book ratioView Telix Pharmaceuticals's return on equityView Telix Pharmaceuticals's dividend yieldView Telix Pharmaceuticals's 52-week price rangeView Telix Pharmaceuticals's revenue growthView Telix Pharmaceuticals's profit marginView all Telix Pharmaceuticals key metricsReturn to Telix Pharmaceuticals profile